4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-014920
President sold 29,675 shares at an average $56.99 ($1,691,056)
- President acquired 29,675 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-02-24 | Option exercise | +15,000 | $6.55 | $98,250 | 15,000 | D: show line 1 in the form |
| RUBINSTEIN JULIE President | 2021-02-24 | Sale | −4,234 | $56.45 | $239,009 | 10,766 | D: show line 2 in the form |
| RUBINSTEIN JULIE President | 2021-02-24 | Sale | −4,134 | $57.12 | $236,134 | 6,632 | D: show line 3 in the form |
| RUBINSTEIN JULIE President | 2021-02-24 | Sale | −3,374 | $58.74 | $198,189 | 3,258 | D: show line 4 in the form |
| RUBINSTEIN JULIE President | 2021-02-24 | Sale | −3,258 | $59.33 | $193,297 | 0 | D: show line 5 in the form |
| RUBINSTEIN JULIE President | 2021-02-25 | Option exercise | +14,675 | $6.55 | $96,121 | 14,675 | D: show line 6 in the form |
| RUBINSTEIN JULIE President | 2021-02-25 | Sale | −14,076 | $56.13 | $790,086 | 599 | D: show line 7 in the form |
| RUBINSTEIN JULIE President | 2021-02-25 | Sale | −599 | $57.33 | $34,341 | 0 | D: show line 8 in the form |
| Open-market sales · 29,675 sh · avg $56.99 · $1,691,056 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-02-24 | Option exercise · Stock Option (Right to Buy) | −15,000 | 270,000 | D: show line 9 in the form | |||||
| RUBINSTEIN JULIE President | 2021-02-25 | Option exercise · Stock Option (Right to Buy) | −14,675 | 255,325 | D: show line 10 in the form |
Loading xslF345X03/doc4.xml…